Stocks
Viatris Inc.VTRS
NASDAQHealthcarePharmaceuticals$13.51-2.10%
A global pharmaceutical company formed through the merger of Mylan and Upjohn, Viatris focuses on providing access to medicines across more than 165 countries. Investors monitor its performance due to its extensive portfolio of branded and generic drugs, including treatments for chronic conditions. The company's strategic positioning in both developed and emerging markets makes it a key player in the pharmaceutical industry.
Market Cap: $15.6B52W Range: $6.85 – $16.47
Congressional Interest in Viatris Inc. (VTRS)
21 members of Congress have disclosed 47 trades in Viatris Inc. (VTRS), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 33 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
47
Unique Politicians
21
Buys
12
Sells
33
Who in Congress Is Trading VTRS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Rohit Khanna | sell | $1K – $15K |
| 2025-11-18 | Gilbert Cisneros | buy | $1K – $15K |